logo
8.1% of urban corporate employees at elevated cardiac risk: MediBuddy Data

8.1% of urban corporate employees at elevated cardiac risk: MediBuddy Data

Time of India01-07-2025
National: Healthcare company MediBuddy has released data showing that approximately 8.1% of urban corporate employees are at elevated cardiac risk, with the 31–40 age group identified as the most vulnerable.
The findings are based on diagnostic reports from 11,779 individuals—9,404 men and 2,370 women—collected between April 2024 and March 2025.
According to the report, 91.9% of participants were classified as low risk, while 2.82% were at moderate risk. In comparison, a recent ICMR-led national study found that only 84.9% of adults were at low risk and 14.4% at moderate risk.
The contrast, MediBuddy suggests, may indicate the positive impact of structured wellness initiatives in the corporate sector, including annual check-ups, access to diagnostics, and health insurance coverage.
The report notes that among individuals aged 31–40—the largest age cohort in the study—10% were found to be at moderate or high cardiac risk, compared to 8% in the 41–50 age group. This early onset of risk factors underscores the potential long-term impact of lifestyle, stress, and dietary habits.
Gender-based findings indicate that 2.06% of women were classified as high cardiac risk. According to ICMR data, 10% of women nationally are at high cardiovascular risk, suggesting that urban corporate women may benefit from greater health awareness and workplace wellness efforts. While men continue to account for 79.9% of high-risk cases, the report suggests a narrowing gender gap due to targeted health interventions.
The report also highlights widespread lipid abnormalities in the urban workforce. Around 45% of participants had high triglyceride levels, 30% showed an unhealthy total lipid ratio, and 11% had elevated LDL levels—known indicators of cardiovascular disease.
According to Dr. Gowri Kulkarni, Head of Medical Operations at MediBuddy, the data reflects an urgent need for early intervention, particularly among younger professionals, to manage cardiovascular risks through clinical care and lifestyle changes.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NSCN-IM chief Thuingaleng Muivah hospitalised
NSCN-IM chief Thuingaleng Muivah hospitalised

Hindustan Times

time12 hours ago

  • Hindustan Times

NSCN-IM chief Thuingaleng Muivah hospitalised

Thuingaleng Muivah, general secretary of the Isak-Muivah-led National Socialist Council of Nagalim (NSCN-IM) involved in peace talks with the central government over the protracted Naga political issue, was hospitalised on Friday over health ailments, people familiar with the matter said. The NSCN (IM) has been in a ceasefire agreement with the government of India since 1997. (HT file photo) The 91-year-old pro-Naga nationalist is being treated at the Christian Institute of Health Sciences and Research (CIHSR) in Dimapur. The persons cited above said his condition is currently stable and under medical supervision. He reportedly complained of indigestion, diarrhoea, difficulty in breathing and other old-age-related issues. Also Read: Naga outfit alleges Central agencies targetting members, warns government The NSCN (IM) which has been in a ceasefire agreement with the government of India since 1997, had signed a 'framework agreement' with the Centre in 2015 and the two have been holding parleys since then, to sign the long drawn out Naga peace deal. The peace talks which is widely considered to be at a 'final stage' has dragged on without much clarity in the past few months, although the Centre's emissary for the Naga peace talks AK Mishra has been frequently visiting Nagaland holding separate meetings with different Naga militant groups and other civil bodies.

India Nears Completion of Phase III Dengue Vaccine Trials
India Nears Completion of Phase III Dengue Vaccine Trials

Hans India

time15 hours ago

  • Hans India

India Nears Completion of Phase III Dengue Vaccine Trials

New Delhi/Hyderabad: The Ministry of Health and Family Welfare has confirmed significant progress in the Phase III trial of India's first dengue vaccine, 'DengiAll.' This clinical study, conducted by the Indian Council of Medical Research (ICMR), aims to evaluate the efficacy of a live attenuated tetravalent vaccine against all four known serotypes of the dengue virus. This update was provided in response to a question raised by Eatala Rajender, a Member of Parliament, during a Lok Sabha session on Friday. The multi-centre trial has enrolled over 10,000 participants, with more than 70% of the enrollment completed. The study is being conducted at 20 designated research centres across India, including key sites such as JSS Medical College and Hospital in Mysore (Karnataka), Bangalore Medical College & Research Institute in Bengaluru (Karnataka), and AIIMS Bibinagar in Hyderabad (Telangana). Each site has been allocated a budget of approximately Rs 1.3 to Rs 1.5 crore. Dengue remains a major public health challenge in India. Data from the Integrated Health Information Platform (IHIP) indicates that there were 573,563 laboratory-confirmed dengue cases reported in 2024, ranking the country among the top 30 worldwide for disease there is no licensed antiviral treatment or vaccine available for dengue in India. The treatment protocol is supportive, following national clinical management guidelines developed by the Union Health Ministry. These guidelines have been shared with all states and Union Territories to enhance preparedness and response capabilities during outbreaks. Given the circulation of all four dengue virus serotypes (DENV-1 to DENV-4) across different regions of India—sometimes even within the same individual—the ICMR has strategically selected trial zones that reflect this viral diversity. This method aims to assess the vaccine's broad-spectrum efficacy. In parallel, the government is implementing efforts under the National Health Mission (NHM), which include vector control measures, fogging operations, public awareness campaigns, and improved surveillance infrastructure. Sentinel Surveillance Hospitals and Apex Laboratories have been established to facilitate free diagnosis and reporting.

AAP, BJP Play Blame Game Over Rising Dengue, Malaria Cases In Delhi
AAP, BJP Play Blame Game Over Rising Dengue, Malaria Cases In Delhi

NDTV

time16 hours ago

  • NDTV

AAP, BJP Play Blame Game Over Rising Dengue, Malaria Cases In Delhi

A blame game has started in Delhi between the Aam Aadmi Party (AAP) and the BJP-led Municipal Corporation of Delhi (MCD) on Friday over the rising cases of vector-borne diseases in the national capital. Both are trading accusations, while health experts warn of a potential surge if timely interventions are not implemented. To put the Rekha Gupta-led BJP government in the dock, the AAP has alleged that malaria cases in Delhi have broken a 10-year record. According to official figures, Delhi has reported 277 dengue cases, 124 malaria infections, and 18 cases of chikungunya so far this monsoon season. AAP Trains Guns At MCD AAP leader Saurabh Bharadwaj said the rising disease numbers reflected larger issues with civic infrastructure. "Malaria cases in Delhi have broken a 10-year record. This isn't just a number, it's a symptom of how deeply mismanaged the city is," he said during a press conference on Friday. Pointing to the instances of waterlogging in Connaught Place, Sadar Bazar, and Janpath, Mr. Bharadwaj said, "BJP ministers repeatedly claim there's no waterlogging, but the rising malaria cases tell a different story. The AAP has also said it will raise the matter in the Delhi Assembly session on August 4. मलेरिया के आंकड़े पिछले 10 साल में सबसे ज़्यादा‼️ BJP की सरकार ने कहा था कि इस बार दिल्ली में जलभराव नहीं होगा लेकिन इस बार CP और सदर बाजार समेत तमाम जगहों पर जलभराव हुआ लेकिन बीजेपी सरकार ने मानने से ही इनकार कर दिया। अब दिल्ली में मलेरिया के आंकड़े पिछले 10 साल के आंकड़े को… — Saurabh Bharadwaj (@Saurabh_MLAgk) August 1, 2025 Mayor Hits Back Responding to the allegations, Delhi Mayor Sardar Raja Iqbal Singh defended the MCD's efforts and questioned AAP's performance during its tenure at the municipal level. AAP ran the MCD for two-and-a-half years. Did they eradicate mosquito breeding? They didn't even release full data on dengue and malaria cases then," Mr Singh said. He also highlighted the civic body's recent initiatives to prevent mosquito breeding and vector-borne diseases, which include spraying at 49,718 locations, conducting 8.2 lakh home inspections, and issuing over 5,600 legal notices for mosquito breeding violations. "We're acting on a war footing. These baseless accusations by AAP are just a political diversion," Mr Singh said, adding that AAP leaders have not been active participants in health discussions. Between Politics and Public Health, Residents Want Solutions As political back and forth continues, residents say they're more concerned about on-ground response than party positions. "We don't want daily updates on blame. We want clean streets, regular spraying, and health camps," said a resident in West Delhi.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store